Is There a Role for Routine p53 Testing in Colorectal Cancer?
- 20 October 2005
- journal article
- editorial
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 23 (30) , 7395-7396
- https://doi.org/10.1200/jco.2005.07.021
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- The TP53 Colorectal Cancer International Collaborative Study on the Prognostic and Predictive Significance of p53 Mutation: Influence of Tumor Site, Type of Mutation, and Adjuvant TreatmentJournal of Clinical Oncology, 2005
- Prognostic Value of Thymidylate Synthase, Ki-67, and p53 in Patients With Dukes’ B and C Colon Cancer: A National Cancer Institute–National Surgical Adjuvant Breast and Bowel Project Collaborative StudyJournal of Clinical Oncology, 2003
- Disruption of p53 in human cancer cells alters the responses to therapeutic agentsJournal of Clinical Investigation, 1999
- Prognostic Value of p53 Genetic Changes in Colorectal CancerJournal of Clinical Oncology, 1999
- p53, guardian of the genomeNature, 1992